临床结果和CRLX101对固体瘤的有效性:系统性审查和元分析
Nahal Shamaeizadeh1, Erfan Sadeghi2, Jaleh Varshosaz1
1Department of Pharmaceutics, Novel Drug Delivery Systems Research Centre, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
Current medicinal chemistry
|February 28, 2024
概括
与传统配方相比,纳米粒子化疗CRLX101显示出更好的无进展生存期 (PFS). 然而,它具有较低的整体存活率 (OS),突出显示了纳米颗粒药物输送和剂量优化的挑战,以提高抗癌疗效.
科学领域:
- 纳米医学是一种纳米医学.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 纳米粒子药物输送可以提高耐受性,减少细胞毒性化疗的毒性.
- 纳米粒子配方与传统配方的有效性仍然是一个关键问题.
- CRLX101是一种纳米颗粒,包括环极和20(S) - 坎プト.
研究的目的:
- 为了比较CRLX101纳米粒子配方与其传统对应物的抗癌疗效.
- 系统地审查随机和非随机临床试验.
主要方法:
- 在多个电子数据库 (PubMed,Scopus,Embase,Web of Science,Cochrane图书馆,clinicaltrials.gov) 中进行了全面的文献搜索.
- 使用随机效应模型方法进行了元分析,以聚合研究特定的中位数.
- 计算了 95% 置信区间的聚合中位数估计.
主要成果:
- 在分析中包括了9项临床研究.
- 与对照组 (6/9试验) 相比,CRLX101的无进展生存时间 (PFS) 中位数更高.
- 与对照组相比,CRLX101显示了较低的平均整体存活 (OS) (5/9试验).
结论:
- 与传统的坎普托塞辛配方相比,CRLX101表现出优异的PFS但劣质的OS.
- 纳米粒子药物输送方面的挑战,包括未解决的药理学和剂量变化,限制了治疗应用.
- 需要对载体介导药物剂量进行进一步的研究,这些药物剂量很少被研究.
更多相关视频
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.3K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K